← All CVEs

CVE-2026-105706

MEDIUM 5.3 PoC AVAILABLE

Published 2026-10-06 · Last modified 2026-10-06

A weakness has been identified in SourceCodester Drug Recommendation System 1.0. Affected is an unknown function. Executing a manipulation can lead to cross-site request forgery. The attack may be performed from remote. The exploit has been made available to the public and could be used for attacks.

EXPLOIT AVAILABLE

Public exploit or PoC code exists. Modeled probability is still low, but the barrier to attack is reduced — watch closely.

Exploitation likelihood

0.2%chance of exploitation in 30 days · 5th percentile

○ In CISA KEV ● Public exploit / PoC

Impact if exploited

5.3CVSS 4.0 · MEDIUM

  • ConfidentialityNone
  • IntegrityLow
  • AvailabilityNone

What an attacker needs

  • ✓Access: Reachable over the network — no local access needed
  • ✓Privileges: No account or privileges required
  • ⚠User interaction: Succeeds with passive user activity
  • ✓Complexity: No special conditions — reliably repeatable
  • ✓Requirements: No special attack requirements

✓ lowers the bar for an attacker · ⚠ raises it

Proof of concept & exploit code

Test against your own equipment

curl -s https://vulnpedia.com/cve/CVE-2026-105706/poc.jsonMachine-readable PoC index for this CVE (for automation).

Listed for defensive triage, patch verification, and authorized testing on systems you own. Machine-readable: /cve/CVE-2026-105706/poc.json

Affected

Vendors Sourcecodester

Products Drug Recommendation System

Weakness (CWE)

  • CWE-352: Cross-Site Request Forgery
  • CWE-862: Missing Authorization

CVSS vector

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P

All CVSS metrics

  • MEDIUM 5.3 v4.0 · CNA Primary
    CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P
  • MEDIUM 4.3 v3.1 · CNA Primary
    CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:N/E:P/RL:X/RC:R
  • MEDIUM 4.3 v3.0 · CNA Primary
    CVSS:3.0/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:N/E:P/RL:X/RC:R
  • MEDIUM 5 v2.0 · CNA Primary
    AV:N/AC:L/Au:N/C:N/I:P/A:N/E:POC/RL:ND/RC:UR
  • LOW 2.1 v4.0 · NVD Secondary
    CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
  • MEDIUM 4.3 v3.1 · NVD Secondary
    CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:N
  • MEDIUM 5 v2.0 · NVD Secondary
    AV:N/AC:L/Au:N/C:N/I:P/A:N

Sources: NVD · CVE.org · EPSS